A Cost-Utility Analysis of Lisdexamfetamine Versus Atomoxetine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Inadequate Response to Methylphenidate
Crossref DOI link: https://doi.org/10.1007/s40263-016-0354-3
Published Online: 2016-08-16
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zimovetz, Evelina A.
Beard, Stephen M.
Hodgkins, Paul
Bischof, Matthias
Mauskopf, Josephine A.
Setyawan, Juliana
Funding for this research was provided by:
Shire Development LLC
License valid from 2016-08-16